Please Wait.....
Report
Heart Attack Diagnostics Market By Type (Electrocardiogram, Blood Tests, Angiogram, Computerized Cardiac Tomography, Others), By End User (Hospitals, Diagnostics Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 260 Pages I Allied Market Research
Heart Attack Diagnostics Market
The heart attack diagnostics market was valued at $9.2 billion in 2023 and is projected to reach $21.1 billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033.
Heart attack diagnostic comprises of diagnosing the blood pressure, temperature, and pulse rate of a patient. A series of evaluations are conducted to determine if an individual has experienced a heart attack, also known as myocardial infarction. The series of diagnostic tests includes an electrocardiogram (EKG) which measures the electrical activity of heart, blood tests to detect cardiac enzymes such as troponin which are released into the bloodstream in case of heart muscle damage, and imaging tests such as coronary angiography or echocardiography for the visualization of heart & its blood vessels.
Increase in sedentary lifestyles has led to surge in occurrence of lifestyle diseases, including heart attack. This has led to surge in demand for heart attack diagnostics, hence augmenting the growth of the market. Furthermore, exponential growth in the geriatric population globally is opening avenues for the expansion of the market. The assimilation of AI in the EKG testing is poised to become mainstream in the future as it reduces the diagnosis time. A hospital in Taiwan conducted research regarding the assimilation of AI and EKG, which reduced the diagnosis period by 10 minutes. Constant improvements in AI are enhancing the efficacy of clinical decision support system, encouraging medical practitioners to adopt the technology.
However, these diagnostics tests are extremely expensive and prevent several end users from leveraging their benefits, hence restraining the market development. In addition, the introduction of new diagnostic technologies is subject to various regulatory hurdles, hence presenting challenges for the expansion of the market. Different regulatory bodies such as the U.S. Food and Drug Administration, European Medicines Agency, the Pharmaceuticals and Medical Devices Agency in Japan, and Central Drugs Standard Control Organization in India have mandated the adherence to their respective regulatory guidelines for the entry of new diagnostic technologies into the market. Contrarily, innovative techniques being introduced into the market are an indicator of its promising future. For instance, Siemens Healthineers, a German healthcare company, has introduced a handheld device which claims to detect heart attack in less than 30 minutes. The launch of such devices is expected to quicken treatment delivery and increase the chances of recovery for patients in the future.
Segment Review
The heart attack diagnostics market is segmented into type, end user, and region. On the basis of type, the market is divided into electrocardiogram, blood tests, angiogram, computerized cardiac tomography, and others. By end user, it is classified into hospitals, diagnostics centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competition Analysis
The major players operating in the global heart attack diagnostics market include Bionet Co., Ltd, TOSHIBA CORPORATION, Bio-Rad Laboratories Inc, Life Sign LLC, Schiller AG, Beckman Coulter,Inc., GE Healthcare, Hitachi Medical Systems, F. Hoffmann-La Roche Ltd., and Abbott Laboratories. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Type
- Electrocardiogram
- Blood Tests
- Angiogram
- Computerized Cardiac Tomography
- Others
By End User
- Hospitals
- Diagnostics Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- Bionet Co., Ltd
- TOSHIBA CORPORATION
- Bio-Rad Laboratories Inc
- Life Sign LLC
- Schiller AG
- Beckman Coulter,Inc.
- GE Healthcare
- Hitachi Medical Systems
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VEHICLE RETARDER MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Product Type
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Hydraulic Retarder
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: VEHICLE RETARDER MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. 18 To 55 MT
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. 55 To 100 MT
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. More Than 100 MT
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: VEHICLE RETARDER MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product Type
6.2.3. Market Size and Forecast, By Application
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Vehicle Retarder Market
6.2.5.1. Market Size and Forecast, By Product Type
6.2.5.2. Market Size and Forecast, By Application
6.2.6. Canada Vehicle Retarder Market
6.2.6.1. Market Size and Forecast, By Product Type
6.2.6.2. Market Size and Forecast, By Application
6.2.7. Mexico Vehicle Retarder Market
6.2.7.1. Market Size and Forecast, By Product Type
6.2.7.2. Market Size and Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product Type
6.3.3. Market Size and Forecast, By Application
6.3.4. Market Size and Forecast, By Country
6.3.5. France Vehicle Retarder Market
6.3.5.1. Market Size and Forecast, By Product Type
6.3.5.2. Market Size and Forecast, By Application
6.3.6. Germany Vehicle Retarder Market
6.3.6.1. Market Size and Forecast, By Product Type
6.3.6.2. Market Size and Forecast, By Application
6.3.7. Italy Vehicle Retarder Market
6.3.7.1. Market Size and Forecast, By Product Type
6.3.7.2. Market Size and Forecast, By Application
6.3.8. Spain Vehicle Retarder Market
6.3.8.1. Market Size and Forecast, By Product Type
6.3.8.2. Market Size and Forecast, By Application
6.3.9. UK Vehicle Retarder Market
6.3.9.1. Market Size and Forecast, By Product Type
6.3.9.2. Market Size and Forecast, By Application
6.3.10. Russia Vehicle Retarder Market
6.3.10.1. Market Size and Forecast, By Product Type
6.3.10.2. Market Size and Forecast, By Application
6.3.11. Rest of Europe Vehicle Retarder Market
6.3.11.1. Market Size and Forecast, By Product Type
6.3.11.2. Market Size and Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product Type
6.4.3. Market Size and Forecast, By Application
6.4.4. Market Size and Forecast, By Country
6.4.5. China Vehicle Retarder Market
6.4.5.1. Market Size and Forecast, By Product Type
6.4.5.2. Market Size and Forecast, By Application
6.4.6. Japan Vehicle Retarder Market
6.4.6.1. Market Size and Forecast, By Product Type
6.4.6.2. Market Size and Forecast, By Application
6.4.7. India Vehicle Retarder Market
6.4.7.1. Market Size and Forecast, By Product Type
6.4.7.2. Market Size and Forecast, By Application
6.4.8. South Korea Vehicle Retarder Market
6.4.8.1. Market Size and Forecast, By Product Type
6.4.8.2. Market Size and Forecast, By Application
6.4.9. Australia Vehicle Retarder Market
6.4.9.1. Market Size and Forecast, By Product Type
6.4.9.2. Market Size and Forecast, By Application
6.4.10. Rest of Asia-Pacific Vehicle Retarder Market
6.4.10.1. Market Size and Forecast, By Product Type
6.4.10.2. Market Size and Forecast, By Application
6.5. Latin America
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product Type
6.5.3. Market Size and Forecast, By Application
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Vehicle Retarder Market
6.5.5.1. Market Size and Forecast, By Product Type
6.5.5.2. Market Size and Forecast, By Application
6.5.6. Argentina Vehicle Retarder Market
6.5.6.1. Market Size and Forecast, By Product Type
6.5.6.2. Market Size and Forecast, By Application
6.5.7. REST of Latin America Vehicle Retarder Market
6.5.7.1. Market Size and Forecast, By Product Type
6.5.7.2. Market Size and Forecast, By Application
6.6. Middle East And Africa
6.6.1. Key Market Trends and Opportunities
6.6.2. Market Size and Forecast, By Product Type
6.6.3. Market Size and Forecast, By Application
6.6.4. Market Size and Forecast, By Country
6.6.5. UAE Vehicle Retarder Market
6.6.5.1. Market Size and Forecast, By Product Type
6.6.5.2. Market Size and Forecast, By Application
6.6.6. Saudi Arabia Vehicle Retarder Market
6.6.6.1. Market Size and Forecast, By Product Type
6.6.6.2. Market Size and Forecast, By Application
6.6.7. South Africa Vehicle Retarder Market
6.6.7.1. Market Size and Forecast, By Product Type
6.6.7.2. Market Size and Forecast, By Application
6.6.8. Rest of Middle East And Africa Vehicle Retarder Market
6.6.8.1. Market Size and Forecast, By Product Type
6.6.8.2. Market Size and Forecast, By Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Frenelsa S.A.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Voith GmbH And Co. KGaA
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. ZF Friedrichshafen AG
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Scania AB.
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Jacobs Vehicle Systems, Inc.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Klam Retarder Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. TBK Co., Ltd.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Shaanxi Fast Auto Drive Group Company Limited
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. SORL Auto Parts, Inc.
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL HEART ATTACK DIAGNOSTICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. HEART ATTACK DIAGNOSTICS MARKET FOR ELECTROCARDIOGRAM, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. HEART ATTACK DIAGNOSTICS MARKET FOR BLOOD TESTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. HEART ATTACK DIAGNOSTICS MARKET FOR ANGIOGRAM, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. HEART ATTACK DIAGNOSTICS MARKET FOR COMPUTERIZED CARDIAC TOMOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 8. HEART ATTACK DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. HEART ATTACK DIAGNOSTICS MARKET FOR DIAGNOSTICS CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. HEART ATTACK DIAGNOSTICS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 15. U.S. HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 16. U.S. HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. CANADA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 18. CANADA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 19. MEXICO HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 20. MEXICO HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. EUROPE HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 22. EUROPE HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 23. EUROPE HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. FRANCE HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 25. FRANCE HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. GERMANY HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 27. GERMANY HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 28. ITALY HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 29. ITALY HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. SPAIN HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 31. SPAIN HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. UK HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 33. UK HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. REST OF EUROPE HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 35. REST OF EUROPE HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 37. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 38. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. CHINA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 40. CHINA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. JAPAN HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 42. JAPAN HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. INDIA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 44. INDIA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. SOUTH KOREA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 46. SOUTH KOREA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 47. AUSTRALIA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 48. AUSTRALIA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. REST OF ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 50. REST OF ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 51. LAMEA HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 52. LAMEA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 53. LAMEA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. BRAZIL HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 55. BRAZIL HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. SOUTH AFRICA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 57. SOUTH AFRICA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. SAUDI ARABIA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 59. SAUDI ARABIA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 60. REST OF LAMEA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 61. REST OF LAMEA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. BIONET CO., LTD: KEY EXECUTIVES
TABLE 63. BIONET CO., LTD: COMPANY SNAPSHOT
TABLE 64. BIONET CO., LTD: OPERATING SEGMENTS
TABLE 65. BIONET CO., LTD: PRODUCT PORTFOLIO
TABLE 66. BIONET CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 67. TOSHIBA CORPORATION: KEY EXECUTIVES
TABLE 68. TOSHIBA CORPORATION: COMPANY SNAPSHOT
TABLE 69. TOSHIBA CORPORATION: OPERATING SEGMENTS
TABLE 70. TOSHIBA CORPORATION: PRODUCT PORTFOLIO
TABLE 71. TOSHIBA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 72. BIO-RAD LABORATORIES INC: KEY EXECUTIVES
TABLE 73. BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
TABLE 74. BIO-RAD LABORATORIES INC: OPERATING SEGMENTS
TABLE 75. BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO
TABLE 76. BIO-RAD LABORATORIES INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 77. LIFE SIGN LLC: KEY EXECUTIVES
TABLE 78. LIFE SIGN LLC: COMPANY SNAPSHOT
TABLE 79. LIFE SIGN LLC: OPERATING SEGMENTS
TABLE 80. LIFE SIGN LLC: PRODUCT PORTFOLIO
TABLE 81. LIFE SIGN LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 82. SCHILLER AG: KEY EXECUTIVES
TABLE 83. SCHILLER AG: COMPANY SNAPSHOT
TABLE 84. SCHILLER AG: OPERATING SEGMENTS
TABLE 85. SCHILLER AG: PRODUCT PORTFOLIO
TABLE 86. SCHILLER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 87. BECKMAN COULTER, INC.: KEY EXECUTIVES
TABLE 88. BECKMAN COULTER, INC.: COMPANY SNAPSHOT
TABLE 89. BECKMAN COULTER, INC.: OPERATING SEGMENTS
TABLE 90. BECKMAN COULTER, INC.: PRODUCT PORTFOLIO
TABLE 91. BECKMAN COULTER, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92. GE HEALTHCARE: KEY EXECUTIVES
TABLE 93. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 94. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 95. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 96. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97. HITACHI MEDICAL SYSTEMS: KEY EXECUTIVES
TABLE 98. HITACHI MEDICAL SYSTEMS: COMPANY SNAPSHOT
TABLE 99. HITACHI MEDICAL SYSTEMS: OPERATING SEGMENTS
TABLE 100. HITACHI MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 101. HITACHI MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 103. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 104. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 105. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 106. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 108. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 109. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 110. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 111. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION
FIGURE 2. GLOBAL HEART ATTACK DIAGNOSTICS MARKET
FIGURE 3. SEGMENTATION HEART ATTACK DIAGNOSTICS MARKET
FIGURE 4. TOP INVESTMENT POCKET IN HEART ATTACK DIAGNOSTICS MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHEART ATTACK DIAGNOSTICS MARKET
FIGURE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION, BY TYPE
FIGURE 12. HEART ATTACK DIAGNOSTICS MARKET FOR ELECTROCARDIOGRAM, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. HEART ATTACK DIAGNOSTICS MARKET FOR BLOOD TESTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. HEART ATTACK DIAGNOSTICS MARKET FOR ANGIOGRAM, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. HEART ATTACK DIAGNOSTICS MARKET FOR COMPUTERIZED CARDIAC TOMOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION, BY END USER
FIGURE 18. HEART ATTACK DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. HEART ATTACK DIAGNOSTICS MARKET FOR DIAGNOSTICS CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: HEART ATTACK DIAGNOSTICS MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. BIONET CO., LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. BIONET CO., LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. BIONET CO., LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. TOSHIBA CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. TOSHIBA CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. TOSHIBA CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. BIO-RAD LABORATORIES INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. BIO-RAD LABORATORIES INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. BIO-RAD LABORATORIES INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. LIFE SIGN LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. LIFE SIGN LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. LIFE SIGN LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. SCHILLER AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. SCHILLER AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. SCHILLER AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. BECKMAN COULTER, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. BECKMAN COULTER, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. BECKMAN COULTER, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. HITACHI MEDICAL SYSTEMS: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. HITACHI MEDICAL SYSTEMS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. HITACHI MEDICAL SYSTEMS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security